Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry
Results 6781 - 500 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
Reset  ↻

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Read more ››
By: GlobeNewswire - 01 Mar 2024
Related companies:  Kura Oncology, Inc.

Iovance Biotherapeutics to Present at Upcoming Conferences

Read more ››
By: GlobeNewswire - 01 Mar 2024
Related companies:  Iovance Biotherapeutics, Inc.

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Read more ››
By: GlobeNewswire - 01 Mar 2024
Related companies:  Taysha Gene Therapies, Inc.

MacroGenics to Participate in Upcoming Investor Conferences

Read more ››
By: GlobeNewswire - 01 Mar 2024
Related companies:  MacroGenics, Inc.

The 16th Zhang Zhongjing Medicine Culture Festival & Forum on High-quality Development of TCM Takes Place in Nanyang, China

Read more ››
By: PR Newswire Association LLC. - 01 Mar 2024

SightMD Clinches Multiple Wins in Best of Long Island 2024 Awards

Read more ››
By: PR Newswire Association LLC. - 01 Mar 2024

Associate Professor Ron Korstanje, Ph.D., of The Jackson Laboratory named Evnin Family Chair

Read more ››
By: PR Newswire Association LLC. - 01 Mar 2024
Related companies:  The Jackson Laboratory | The Jackson Laboratory

GreenVenus™ and Plant Research (NZ) LTD partner to develop climate-resilient field pea varieties and deliver clean protein solutions for human and pet food markets

Read more ››
By: PR Newswire Association LLC. - 01 Mar 2024

RYBREVANT® (amivantamab-vmjw) in Combination With Chemotherapy Is the First FDA Approved Therapy for First-line Treatment of Patients With Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

Read more ››
By: PR Newswire Association LLC. - 01 Mar 2024
Related companies:  Johnson & Johnson, Inc.

Gateways Hospital and Mental Health Center Opens New Sensory Room, Providing Vulnerable Clients with Innovative, Client-Centered Care

Read more ››
By: PR Newswire Association LLC. - 01 Mar 2024

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Read more ››
By: PR Newswire Association LLC. - 01 Mar 2024
Related companies:  Syndax Pharmaceuticals, Inc.

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Read more ››
By: PR Newswire Association LLC. - 01 Mar 2024
Related companies:  Akebia Therapeutics, Inc.

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Read more ››
By: PR Newswire Association LLC. - 01 Mar 2024
Related companies:  Karyopharm Therapeutics Inc.

Aadi Bioscience Announces Publication of Long-Term Efficacy and Safety Data Further Supporting FYARRO® for the Treatment of Malignant PEComa

Read more ››
By: PR Newswire Association LLC. - 01 Mar 2024
Related companies:  Aadi Bioscience, Inc.

FDA Roundup: March 1, 2024

Read more ››
By: PR Newswire Association LLC. - 01 Mar 2024
Related companies:  U.S. Food and Drug Administration

Mezzion Pharmaceuticals Announces Dr. Rahul Rathod of Boston Children's Hospital and Harvard Medical School as the Global Principal Investigator for the Confirmatory Pivotal Phase 3 Trial FUEL-2

Read more ››
By: PR Newswire Association LLC. - 01 Mar 2024
Related companies:  Mezzion Pharmaceuticals, Inc

Spyre Therapeutics Announces Grants of Inducement Awards

Read more ››
By: PR Newswire Association LLC. - 01 Mar 2024
Related companies:  Spyre Therapeutics, Inc.

Multiplex Assays Markets, 2030

Read more ››
By: PR Newswire Association LLC. - 01 Mar 2024

Epigenetics Market Research Report 2023-2030: DNA Methylation and Oncology Applications At the Forefront of Advancements

Read more ››
By: PR Newswire Association LLC. - 01 Mar 2024

Global Cancer/Tumor Profiling Market Research Report 2023-2030: Multi-Omics Tumor Profiling Advances Fuel Developments, Rising Personalized Medicine Trends Driving Growth

Read more ››
By: PR Newswire Association LLC. - 01 Mar 2024
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
Terms of Use & Privacy Policy
to the top ↑